Investor Relations
Event Details
European Society of Medical Oncology (ESMO) Virtual Congress 2021
Sep 16 - Sep 21, 2021
Title: Dual targeting PD-1 and BRD4 with INTASYL self-delivering RNAi elicits persistent anti-tumor immunity in-vivo following complete resolution of tumors
Authors: Benjamin Cuiffo, et al.
Abstract Number: #4154